For Research Use Only · Not For Human or Veterinary Use · UK Research Compounds

RESEARCH USE ONLY · Not for human or veterinary useTracked UK delivery | Customer support
Premium Research Peptide

CJC/IPA BLEND 20MG

£89.98 GBP
● In stock · Ready to dispatch

Pre-combined GHRH-analog blend for research convenience.

Orders dispatch after payment confirmation. Tracked UK delivery on eligible catalogue items.
Search the COA library

Pre-combined GHRH-analog blend for research convenience.

UK Dispatch
Order Processing
Tracked Delivery
Expert Support
Need wholesale research pricing?Volume options for qualified laboratories and research organizations.View wholesale options ↗
For Research Use Only (RUO). This product is supplied exclusively for in vitro laboratory research. It is not licensed for human or veterinary use, is not a medicine or medicinal product, and must not be administered to humans or animals. By purchasing, you confirm that you are a qualified researcher and will handle the material in accordance with applicable UK legislation and your institution’s health and safety requirements. EVLV UK accepts no liability for misuse.
Ask a Lab Specialist →
CJC/IPA BLEND 20MG£89.98 GBP
Product information

Product description

CJC-1295 / Ipamorelin 20mg blend supplied for laboratory analytical research, independently tested for identity and mass.

EVLV fulfills research products from the United States and publishes product-specific batch documentation when a matching laboratory report is available. Testing methods and results are specific to the product and batch identified in each report.

This product is supplied in the format shown on this page: lyophilized powder.

For laboratory research use only. Not for human or veterinary use.

At a glance

Research specifications

Product
CJC/IPA BLEND 20MG
SKU
CP20
Purity
See current COA
Form
Lyophilized powder
CAS number
863288-34-0, 170851-70-4
Verified content
20.2 mg

Compound research context

Evaluate CJC/IPA BLEND 20MG beyond the label.

A dual-component label identifies the intended composition but does not verify an individual sample. The analytical record should name the blend, identify the sample, and provide appropriate results for both CJC-1295 no DAC and Ipamorelin.

Open the complete CJC/Ipamorelin research hub

Classification

CJC-1295 no DAC and Ipamorelin research blend

Classification organizes the research catalogue. It is not a claim of safety, efficacy, or approved use.

Analytical review

Match product, strength, and lot

Confirm the listed strength and sample identifier, then evaluate CJC-1295 and Ipamorelin results separately. Also review the issuing laboratory, test date, and analytical methods stated in the report.

Available strengths

Compare separate listings

Product-specific questions

What does the EVLV CJC/Ipamorelin Blend contain?

The listing identifies CJC-1295 no DAC and Ipamorelin as the two named research components.

Are both components reported on the COA?

Review the exact report for the methods and results stated for each analyte. Do not infer one component from the other.

Can documentation be shared between blend strengths?

Only when the report explicitly identifies the applicable product and sample. Each strength keeps a separate documentation status.